Charles Schwab Investment Management Inc Alnylam Pharmaceuticals, Inc. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 447,560 shares of ALNY stock, worth $109 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
447,560
Previous 438,304
2.11%
Holding current value
$109 Million
Previous $83.9 Million
20.27%
% of portfolio
0.02%
Previous 0.02%
Shares
27 transactions
Others Institutions Holding ALNY
# of Institutions
584Shares Held
104MCall Options Held
2.82MPut Options Held
1.75M-
Capital World Investors Los Angeles, CA12.8MShares$3.11 Billion0.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$2.91 Billion0.04% of portfolio
-
Black Rock Inc. New York, NY9.03MShares$2.19 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA7.21MShares$1.75 Billion0.2% of portfolio
-
Baillie Gifford & CO6.62MShares$1.61 Billion0.78% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $29.9B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...